WEX granted patents in China, Ukraine pain management

By Lisa Kerner

Charlotte, N.C., Aug. 28 - WEX Pharmaceuticals Inc. said it was granted patent ZL 01 1 18098.6 by the State Intellectual Property Office of the People's Republic of China and patent UA 2003032528 by the State Department of Intellectual Property of Ukraine.

The first patent claims an analgesic composition comprising an opioid analgesic agent and a binding compound which reduces use of morphine. WEX holds U.S. Patent No. 6,780,866 on this combination.

The second patent, covering the use of TTX and other similar compounds for pain management, relates to a method of producing analgesia in mammals, including human beings, using a sodium channel blocking compound such as TTX. WEX holds the U.S. patent for the invention.

WEX, located in Vancouver, B.C., discovers, develops, manufactures and commercializes drug products to treat pain.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.